| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 07/08/2010 | WO2010078421A1 Substituted 5,6-dihydro-6-phenylbenzo[f] isoquinolin-2-amine compounds |
| 07/08/2010 | WO2010077992A1 Aminopyridine and carboxypyridine compounds as phosphodiesterase 10 inhibitors |
| 07/08/2010 | WO2010077947A1 Phthalazinone and related analogs as sirtuin modulators |
| 07/08/2010 | WO2010077836A2 Pyrrolidine compounds which modulate the cb2 receptor |
| 07/08/2010 | WO2010077686A1 Isoindolinone and related analogs as sirtuin modulators |
| 07/08/2010 | WO2010077586A1 N-(1-phenyl-2-arylethyl)-4,5-dihydro-3h-pyrrol-2-amine compounds as subtype selective modulators of alpha2b or alpha2b and alpha2c adrenoceptors |
| 07/08/2010 | WO2010077275A1 Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto |
| 07/08/2010 | WO2010076764A1 Irreversible egfr inhibitor compounds with antiproliferative activity |
| 07/08/2010 | WO2010076566A2 Indoles useful in the treatment of inflammation |
| 07/08/2010 | WO2010076525A1 Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof |
| 07/08/2010 | WO2010076524A2 Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof as hif activators |
| 07/08/2010 | WO2010076474A1 Method for preparing activated esters |
| 07/08/2010 | WO2010076238A1 Substituted quinazoline compounds |
| 07/08/2010 | WO2010076034A1 Toluidine sulfonamides and their use as-inhibitors |
| 07/08/2010 | WO2010075973A1 Substituted 4-(1,2,3,4-tetrahydroisochinolin-2-yl)-4-oxo-butyric acid amide as kcnq2/2 modulators |
| 07/08/2010 | WO2010056633A3 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones |
| 07/08/2010 | WO2010055164A3 Isoquinolone derivatives as inhibitors of plavivirus replication |
| 07/08/2010 | WO2010037054A3 Heteroaryl antagonists of prostaglandin d2 receptors |
| 07/08/2010 | WO2010028254A3 Substituted quinazoline inhibitors of growth factor receptor tyrosine kinases |
| 07/08/2010 | WO2009143039A3 Heterocyclic compounds as factor ixa inhibitors |
| 07/08/2010 | US20100174087 Process for preparation of enantiomerically pure esomeprazole |
| 07/08/2010 | US20100174086 Electron-transporting materials and processes for making the same |
| 07/08/2010 | US20100174082 (1r,1'r)-atracurium salts separation process |
| 07/08/2010 | US20100174074 Novel benzophenone hybrids as potential anticancer agents and a process for the preparation thereof |
| 07/08/2010 | US20100173949 Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof |
| 07/08/2010 | US20100173946 Benzimidazolylidene propane-1,3-dione derivative or salt thereof |
| 07/08/2010 | US20100173944 Helicobacter pylori eradicating agent having inhibitory activity on gastric acid secretion |
| 07/08/2010 | US20100173942 Phosphodiesterase 4 inhibitors |
| 07/08/2010 | US20100173935 Muscarinic Receptor Agonists that are Effective in the Treatment of Pain, Alzheimer's Disease and Schizophrenia |
| 07/08/2010 | US20100173925 Oxyindole derivatives |
| 07/08/2010 | US20100173924 Novel heterocycle compounds and uses thereof |
| 07/08/2010 | US20100173909 Piperidine compounds and uses thereof - 596 |
| 07/08/2010 | US20100173908 Substituted n-phenyl-bipyrrolidine ureas and therapeutic use thereof |
| 07/08/2010 | US20100173901 Substituted Heterocyclic Compounds |
| 07/08/2010 | US20100173899 Dipeptide analogs as coagulation factor inhibitors |
| 07/08/2010 | US20100173898 Substituted n-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof |
| 07/08/2010 | US20100173897 Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof |
| 07/08/2010 | US20100173891 Heterocyclic compounds, methods for the preparation thereof, and uses thereof |
| 07/08/2010 | US20100173888 Nicotinamide Derivatives |
| 07/08/2010 | US20100173851 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 07/08/2010 | US20100173413 Pyridine compounds |
| 07/08/2010 | US20100171417 Charge transport material and organic electroluminescence device |
| 07/08/2010 | CA2748607A1 Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
| 07/08/2010 | CA2748491A1 Substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds |
| 07/08/2010 | CA2748413A1 Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof |
| 07/08/2010 | CA2748411A1 Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof as hif activators |
| 07/08/2010 | CA2747602A1 3.1.0 bicyclic glyt1 inhibitors and methods of making and using same |
| 07/08/2010 | CA2747158A1 Phthalazinone and related analogs as sirtuin modulators |
| 07/08/2010 | CA2747105A1 Method for preparing activated esters |
| 07/08/2010 | CA2747094A1 Substituted 4-(1,2,3,4-tetrahydroisoquinolin-2-yl)-4-oxobutyric acid amide as kcnq2/3 modulators |
| 07/08/2010 | CA2746307A1 Aminopyridine and carboxypyridine compounds as phosphodiesterase 10 inhibitors |
| 07/08/2010 | CA2746295A1 N-(1-phenyl-2-arylethyl)-4,5-dihydro-3h-pyrrol-2-amine compounds as subtype selective modulators of alpha2b or alpha2b and alpha2c adrenoceptors |
| 07/08/2010 | CA2746221A1 Isoindolinone and related analogs as sirtuin modulators |
| 07/07/2010 | EP2203442A1 Substituted pyrrolo-pyrimidine derivatives, process for their preparation and their use as kinase inhibitors |
| 07/07/2010 | EP2203441A2 Process for optically active sulfoxide compounds |
| 07/07/2010 | EP2203440A1 Inhibitors of the interaction between mdm2 and p53 |
| 07/07/2010 | EP2203439A1 1',3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2h, 1'h-ý1, 4'¨bipyridinyl-2'-ones |
| 07/07/2010 | EP2203438A1 Cyanoisoquinoline |
| 07/07/2010 | EP2203437A1 Chiral cis-imidazolines |
| 07/07/2010 | EP2203436A1 Pyrazine derivatives and their use as potassium channel modulators |
| 07/07/2010 | EP2203435A2 6, 11-bridged biaryl macrolides |
| 07/07/2010 | EP2203431A1 Anti-infective pyrimidines and uses thereof |
| 07/07/2010 | EP2203430A1 N-phenyl-dioxo-hydropyrimidines useful as hepatitis c virus (hcv) inhibitors |
| 07/07/2010 | EP2203429A1 Pyridazinone derivatives and use thereof as p2x7 receptor inhibitors |
| 07/07/2010 | EP2203427A2 5-aryl-4,5-dihydro-(1h)-pyrazoles as cannabinoid cb1 receptor agonists |
| 07/07/2010 | EP2203426A1 Benzenesulfonamide compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 07/07/2010 | EP2203424A1 Indole compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (s1p) receptor biological activity |
| 07/07/2010 | EP2203423A1 Indoline compounds |
| 07/07/2010 | EP2029529B1 Substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 07/07/2010 | EP1861380B1 2-(4-oxo-4h-quinazolin-3-yl)acetamides and their use as vasopressin v3 antagonists |
| 07/07/2010 | EP1851212B1 New process for synthesis of proton pump inhibitors |
| 07/07/2010 | EP1597244B1 Ethynyl derivatives serving as factor xa inhibitors |
| 07/07/2010 | EP1487806B1 4-anilino quinazoline derivatives as antiproliferative agents |
| 07/07/2010 | EP1485099B1 Inhibitors of histone deacetylase |
| 07/07/2010 | CN101772495A fungicide 2-pyridyl-methylene-thio carboxamide or 2-pyridyl-methylene-n-substituted carboximidamide derivatives |
| 07/07/2010 | CN101772493A gamma secretase modulators |
| 07/07/2010 | CN101772492A Use of N,N'-bis(1,1-dihydroperfluoro-C3-C5-alkyl)perylene-3,4:9,10-tetracarboxylic diimides |
| 07/07/2010 | CN101772486A Fungicide n-6-membered fused (hetero)aryl-methylene-n-cycloalkyl carboxamide derivatives |
| 07/07/2010 | CN101768161A Nitrogen-containing heterocyclic compound with pesticidal activity, preparation and application thereof |
| 07/07/2010 | CN101768152A Piperidine derivatives useful as CCR5 antagonists |
| 07/07/2010 | CN101768151A 2-(2-pyridyl)-8-sulfonamidoquinoline derivative, synthesis method and application thereof |
| 07/07/2010 | CN101768125A Triazole compound and preparation method thereof |
| 07/06/2010 | USRE41425 Piperazine and piperidine compounds |
| 07/06/2010 | US7750161 N-Cyclopropyl-N-(1-{2-[3-(2,6-dimethyl-pyridin-4-yl)-ureido]-ethyl}-piperidin-4-yl)-2-fluoro-benzenesulfonamide; 2-(4-Chloro-phenyl)-N-(1-{2-[3-(2,6-dimethyl-pyridin-4-yl)-ureido]-ethyl}-piperidin-4-yl)-N-methyl-acetamide; neurohormonal antagonists |
| 07/06/2010 | US7750156 1-(4-hydroxyphenyl)-4-(4-trifluoromethoxyphenoxy) piperidine; amination; produced at a high yield and a high purity without using expensive catalysts |
| 07/06/2010 | US7750154 Amide derivatives |
| 07/06/2010 | US7750151 Inhibitors of Akt activity |
| 07/06/2010 | US7750150 Process for producing acid adduct salt of polyacidic base compound |
| 07/06/2010 | US7750032 Compounds and compositions as PPAR modulators |
| 07/06/2010 | US7750027 Compounds having CRTH2 antagonist activity |
| 07/06/2010 | US7750026 N-Cyclopropyl-3-[5-fluoro-3-(4-pyridinyl)-1H-indazol-6-yl]-4-methylbenzamide, useful in the treatment of conditions or disease states mediated by p38 mitogen-activated protein kinase activity or mediated by cytokines produced by the activity of p38 mitogen-activated protein kinases |
| 07/06/2010 | US7750025 Derivatives of N-phenyl (piperidine-2-yl) methyl benzamide, preparation method thereof and applications of same in therapeutics |
| 07/06/2010 | US7750011 Diazabicyclic aryl derivatives and their medical use |
| 07/06/2010 | US7750010 2-(2,5-Dioxo-5,6-dihydro-4H-imidazo[1,5,4-de]quinoxalin-1(2H)-yl)-N-(3-methyl-spiro[imidazolidine-4,2'-indane]-2,5-dione)acetamide, used as Calcitonin Gene-Related Peptide (CGRP), ligands useful in the treatment or prevention of headaches |
| 07/06/2010 | US7750006 e.g. 4-[5-(Piperidine-1-carbonyl)-furan-2-ylmethyl]-2H-phthalazin-1-one; enzyme poly(ADP-ribose)polymerase (synthase)-1 or poly ADP-ribosyltransferase (PARP-1) inhibitor; anticarcinogenic agent with BRCA2 deficient phenotype; septic shock; ischemic injury; hemorrhagic shock; multiple sclerosis |
| 07/06/2010 | CA2539479C Isoquinoline potassium channel inhibitors |
| 07/06/2010 | CA2454863C Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine |
| 07/06/2010 | CA2391425C Transition metal complexes with bidentate ligand having an imidazole ring |
| 07/06/2010 | CA2359462C Pyrazole compounds and uses thereof |
| 07/01/2010 | WO2010075271A1 Bicyclic heterocycle derivatives and methods of use thereof |